ProCE Banner Activity

Expert Guidance on Harnessing New Therapeutic Approaches in Ulcerative Colitis Slideset

Slideset

Download these slides to learn how the introduction of S1P receptor modulators and JAK inhibitors for treating UC has the potential to revolutionize the therapeutic landscape. Read the latest from expert faculty on the place in therapy for these agents to help improve clinical and patient-oriented health outcomes.

Released: October 30, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Pfizer, Inc.

Pfizer, Inc.